Catalytic Reduction and Biofilm Oxidation for TCA, TCE, and 1,4-Dioxane Removal

The system divides the contaminant removal process into two sequential stages: a catalytic reduction stage using Pd nanoparticles to convert TCA/TCE to less toxic compounds, followed by a biological oxidation stage to degrade these compounds. This segmentation allows each stage to operate under optimized conditions, with the catalytic stage achieving rapid reduction without requiring long retention times, while the biological stage efficiently degrades the transformed compounds.

The patent introduces Pd nanoparticles as an intermediary catalyst that mediates the transformation of TCA/TCE into intermediate products (ethane, ethene) that are more amenable to biological degradation. This intermediary catalytic step accelerates the overall process, reducing the required hydraulic retention time while maintaining cost-effectiveness through the use of nanoparticle catalysts.

The system segments the treatment process into two distinct functional stages: first, catalytic reduction of TCA and TCE to ethane and ethene using Pd nanoparticles; second, biological oxidation of these reduced products. This segmentation eliminates mutual inhibition between TCA and TCE during the same process stage, as each contaminant is transformed independently in the catalytic stage before being processed biologically in the second stage.

The patent changes the fundamental mechanism from simultaneous biological reduction to sequential catalytic then biological treatment. By altering the process parameters and mechanism, the system avoids the mutual inhibition problem that plagues simultaneous bioreduction, achieving reliable and efficient treatment of both TCA and TCE without interference between the contaminants.

The patent employs Pd nanoparticles as a catalyst that can be easily replenished or replaced. These nanoparticles provide high catalytic activity for the reduction of TCA/TCE but are small enough to be cost-effective and can be regenerated or replaced without significant expense, avoiding the high energy input and deactivation issues associated with traditional bulk metal catalysts.

The system changes the catalytic approach by using nanoparticle-scale Pd catalysts instead of traditional bulk metals. This parameter change at the nanoscale increases surface area and catalytic efficiency, reducing the total metal required and lowering energy input requirements while maintaining high removal efficiency for TCA and TCE.

The system performs preliminary catalytic reduction of TCA and TCE before the biological oxidation stage. By transforming these contaminants into ethane and ethene in advance, the biological stage only needs to oxidize these simpler compounds along with 1,4-D, reducing the need for excessive electron donors and carbon sources that would otherwise be required to handle the more resistant chlorinated solvents.

The Pd nanoparticle catalyst acts as an intermediary that prepares the contaminants for biological degradation. By converting TCA/TCE into more biodegradable forms, the catalyst enables efficient biological oxidation of 1,4-D and the reduced products without requiring large amounts of external electron donors and carbon sources, thus preventing secondary contamination from unused additives.